Prostate Cancer research at TGen

Prostate Cancer is a deadly disease that took the lives of nearly 31,000 American men in 2001. It is estimated that more than 230,000 new cases will be diagnosed in 2004. Prostate cancer is the most common cancer and the second leading cause of cancer death in men.

There are few prostate cancer-specific drugs available even after decades of research. TGen's mission is to accelerate the search for genes that cause prostate cancer and discover potential new drug targets.

Researchers at TGen are focused on searching for genetic identifiers that will act as predictors for prostate cancer. TGen is currently conducting the most in-depth study of its kind designed to scan the genomes of 112 families with prostate cancer to identify genetic risk factors for the disease. Once these risk factors are identified, scientists can use that information to develop diagnostic and prognostic tools to help physicians treat their patients.

Category:

Science & Technology

Tags:

• TGen
• medicine
• nonprofit
• translational
• genomic
• genetic
• research
• prostate
• cancer